These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26860639)

  • 1. Novel Human Three-Domain Antibody Fragments Against sTNFα as Well as tmTNFα with High Affinity Generated by the Combination of Ribosome Display and E. coli Expression System.
    Zhao XL; Tian LF; Zhang SJ; Li JM; Feng H; Wang LM; Wang S; Wang J; Wang T; Chen WQ
    Scand J Immunol; 2016 Apr; 83(4):267-78. PubMed ID: 26860639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.
    Edwards CK; Bendele AM; Reznikov LI; Fantuzzi G; Chlipala ES; Li L; Moldawer LL; Mountz JD; Li YY; Dinarello CA
    Arthritis Rheum; 2006 Sep; 54(9):2872-85. PubMed ID: 16947419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
    Benoot T; Piccioni E; De Ridder K; Goyvaerts C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
    Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.
    Goodall LJ; Ovecka M; Rycroft D; Friel SL; Sanderson A; Mistry P; Davies ML; Stoop AA
    PLoS One; 2015; 10(9):e0137065. PubMed ID: 26352810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
    Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
    J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
    Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
    Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of human antibodies to TNF-alpha using ribosome display technology].
    Zhao XL; Chen WQ; Li JM; Zhang SJ; Tian LF; Wang L; Gong JB; Yang ZH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):145-9. PubMed ID: 19174012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual function of human necrosis factor receptor 75 in cytotoxicity induced by human tumor necrosis factor alpha.
    Fang J; Lu F; Chen CQ
    Acta Pharmacol Sin; 2001 Nov; 22(11):1039-44. PubMed ID: 11749798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ribosome display screening of a novel human anti-IgE scFv fragment].
    Zhang YX; Wang BC; Yu X; Dai YJ; He YZ; Cong C; Xia Y; Wang MR
    Yao Xue Xue Bao; 2012 Oct; 47(10):1329-35. PubMed ID: 23289145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and modification of anti-rhTNF-α single chain variable fragment antibody: effective in vitro affinity maturation and functional expression of chimeric Fab.
    Miao X; Li A; Chen W; Qi H; Qiu Z; Zhang Y; Zhang J; Wang M
    Biomed Pharmacother; 2013 Jun; 67(5):437-44. PubMed ID: 23582792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
    Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
    MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli.
    Jia D; Yang H; Wan L; Cheng J; Lu X
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2345-55. PubMed ID: 22207214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering and characterization of a humanized antibody targeting TNF-α and RANKL.
    Wang J; Du Y; Qian H; Yu H; Li S; Zhang X; Li Z; Yuan H; Zhao W
    Biochem Biophys Res Commun; 2014 Jul; 450(1):717-22. PubMed ID: 24950406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNFα.
    Shen Y; Li G; Gu C; Chen B; Chen A; Li H; Gao B; Liang C; Wu J; Yang T; Jin L; Su Y
    PLoS One; 2017; 12(5):e0177891. PubMed ID: 28542350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc.
    Richter F; Seifert O; Herrmann A; Pfizenmaier K; Kontermann RE
    MAbs; 2019; 11(4):653-665. PubMed ID: 30929560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.